The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis.
暂无分享,去创建一个
Gordon Cooke | Nik Hirani | M. Keane | C. Hogaboam | D. O’Dwyer | P. Fallon | A. Millar | S. Donnelly | A. Simpson | M. Whyte | Padraic G Fallon | N. Hirani | David N O'Dwyer | Michelle E Armstrong | Seamas C Donnelly | M. E. Armstrong | G. Cooke | E. Mcgrath | Michael P Keane | Glenda Trujillo | A John Simpson | Ann B Millar | Emmet E McGrath | Moira K Whyte | Cory M Hogaboam | G. Trujillo | M. Whyte | Cory M. Hogaboam | Seamas C. Donnelly | David N. O’Dwyer | Michelle E. Armstrong | Michael P. Keane | Padraic G. Fallon | A. John Simpson | Ann B. Millar | Emmet E. McGrath | Moira K. Whyte | Moira K B Whyte
[1] B. Moore,et al. Viruses as co-factors for the initiation or exacerbation of lung fibrosis , 2008, Fibrogenesis & tissue repair.
[2] A. Smahi,et al. TLR3 Deficiency in Patients with Herpes Simplex Encephalitis , 2007, Science.
[3] A. Nicholson,et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. , 2003, American journal of respiratory and critical care medicine.
[4] R. Hubbard,et al. The rising incidence of idiopathic pulmonary fibrosis in the UK , 2011, Thorax.
[5] K. Welsh,et al. Analysis of Tumor Necrosis Factor- α , Lymphotoxin- α , Tumor Necrosis Factor Receptor II, and Interleukin-6 Polymorphisms in Patients with Idiopathic Pulmonary Fibrosis , 2001 .
[6] W. Chung,et al. Small Interfering RNAs Induce Macrophage Migration Inhibitory Factor Production and Proliferation in Breast Cancer Cells via a Double-Stranded RNA-Dependent Protein Kinase-Dependent Mechanism1 , 2008, The Journal of Immunology.
[7] J. Stewart,et al. Herpes Virus Infection Is Associated with Vascular Remodeling and Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis , 2013, PloS one.
[8] A. Motala,et al. Toll-like receptor 3 gene polymorphisms in South African Blacks with type 1 diabetes. , 2005, Tissue antigens.
[9] D. Weissman,et al. mRNA Is an Endogenous Ligand for Toll-like Receptor 3* , 2004, Journal of Biological Chemistry.
[10] A. Gruber,et al. Deletion of TLR3 Alters the Pulmonary Immune Environment and Mucus Production during Respiratory Syncytial Virus Infection , 2006, The Journal of Immunology.
[11] F. Martinez,et al. Recent advances in idiopathic pulmonary fibrosis. , 2007, Chest.
[12] Takeshi Johkoh,et al. American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .
[13] J. Norris,et al. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. , 2007, American journal of respiratory and critical care medicine.
[14] D. Chaussabel,et al. Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood , 2012, The Journal of experimental medicine.
[15] S. Akira,et al. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.
[16] S. Kunkel,et al. TLR3 modulates immunopathology during a Schistosoma mansoni egg‐driven Th2 response in the lung , 2008, European journal of immunology.
[17] N. Kaminski,et al. Accelerated Variant of Idiopathic Pulmonary Fibrosis: Clinical Behavior and Gene Expression Pattern , 2007, PloS one.
[18] J. Towbin,et al. A Role for Toll-like Receptor 3 Variants in Host Susceptibility to Enteroviral Myocarditis and Dilated Cardiomyopathy* , 2010, The Journal of Biological Chemistry.
[19] Ruslan Medzhitov,et al. Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.
[20] L. Leng,et al. Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosis. , 2012, American journal of respiratory and critical care medicine.
[21] K. Brown,et al. Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. , 2009, Chest.
[22] R. Bucala. Review Series - Inflammation & Fibrosis , 2012 .
[23] B. Moore,et al. Exacerbation of Established Pulmonary Fibrosis in a Murine Model by Gammaherpesvirus at a Glance Commentary , 2022 .
[24] G. Parmigiani,et al. Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. , 2008, The New England journal of medicine.
[25] L. Fan,et al. Toll‐like receptor 3 C1234T may protect against geographic atrophy through decreased dsRNA binding capacity , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[27] J. Mullol,et al. Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.
[28] B. Moore,et al. Viral infection and aging as cofactors for the development of pulmonary fibrosis , 2010, Expert review of respiratory medicine.
[29] B. Uhal,et al. Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression , 2008, European Respiratory Journal.
[30] Haitao Wen,et al. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events , 2008, The Journal of experimental medicine.
[31] G. Raghu,et al. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.
[32] E. B. Meltzer,et al. Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44 , 2011, The Journal of experimental medicine.
[33] D. Hyde,et al. Ameliorating effect of murine interferon gamma on bleomycin-induced lung collagen fibrosis in mice. , 1986, Biochemical medicine and metabolic biology.
[34] T. Hara,et al. Association of toll-like receptor 3 gene polymorphism with subacute sclerosing panencephalitis , 2011, Journal of NeuroVirology.
[35] W. Miller,et al. Effects of Single Nucleotide Polymorphisms on Toll-like Receptor 3 Activity and Expression in Cultured Cells* , 2007, Journal of Biological Chemistry.
[36] S. Sahn,et al. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial , 2009, The Lancet.
[37] O. Eickelberg,et al. Molecular mechanisms of TGF‐β antagonism by interferon γ and cyclosporine A in lung fibroblasts , 2001 .
[38] T. Sethi,et al. Treatments in idiopathic pulmonary fibrosis: time for a more targeted approach? , 2012, QJM : monthly journal of the Association of Physicians.
[39] N. Kaminski,et al. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. , 2012, American journal of respiratory and critical care medicine.
[40] B. Moore,et al. Latent herpesvirus infection augments experimental pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.
[41] H. Collard,et al. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. , 2003, American journal of respiratory and critical care medicine.
[42] W. Travis,et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. , 2005, American journal of respiratory and critical care medicine.
[43] N. Todd,et al. Molecular and cellular mechanisms of pulmonary fibrosis , 2012, Fibrogenesis & tissue repair.
[44] S. Donnelly. Review Series--Inflammation & Fibrosis. Introduction. , 2012, QJM : monthly journal of the Association of Physicians.
[45] S. Kudoh,et al. Interferon-{beta} inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor-{beta} and thrombospondin. , 2005, American journal of respiratory cell and molecular biology.
[46] P. Sime,et al. INVITED REVIEW SERIES: PULMONARY FIBROSIS , 2009 .
[47] K. Brown,et al. Clinical trials and tribulations--lessons from pulmonary fibrosis. , 2012, QJM : monthly journal of the Association of Physicians.
[48] H. Collard,et al. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.
[49] B. Berman,et al. Persistence of a reduced-collagen-producing phenotype in cultured scleroderma fibroblasts after short-term exposure to interferons. , 1987, The Journal of clinical investigation.
[50] Thomas A. Wynn,et al. Integrating mechanisms of pulmonary fibrosis , 2011, The Journal of experimental medicine.
[51] K. Kawa,et al. Epstein-Barr virus (EBV)–encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3 , 2009, The Journal of experimental medicine.
[52] T. Moore,et al. TLR9-induced interferon β is associated with protection from gammaherpesvirus-induced exacerbation of lung fibrosis , 2011, Fibrogenesis & tissue repair.